Rose Pharma LLC

Novo Nordisk A/s

Ares Trading S.a.

Coriolis Pharma Research Gmbh

Andrea Hawe

Enda Kenny

Richard J Warburg

Olimpia Popko

Eva Keilhauer

Alessandra Del Rio

Gianluca Rinaldi

Wim Jiskoot

Ariadna Martos-Sánchez

Stefan Heindl

Ruedeeporn Tantipolphan

Joseph Alexander Soto

Angelika Freitag

Ariadna Martos-SÁNCHEZ

Daniel Weinbuch

Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.

Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof

The invention provides antibody formulations and methods useful for prophylaxis or treatment of transthyretin-related amyloidosis.

Lyophilized formulation of a monoclonal antibody against transthyretin

The present invention relates to a method for the quantification of a polysorbate in a sample, comprising the steps of a) providing a sample, comprising at least one polysorbate; b) combining the sample with a carbocyanine dye; c) measuring fluorescence of the mixture; and d) correlating said fluorescence with the amount of polysorbate.

Polysorbate quantification assay

Stable liquid formulations of glucagon-like peptide 1 or analogues thereof

The present invention relates to novel liquid protein formulations, particularly arginine-free liquid pharmaceutical compositions of etanercept. The invention employs particular combinations and classes of buffer systems, tonicifiers, and sugar stabilisers, optionally alongside polar ionisable amino acids (e.g. aspartic acid, glutamic acid, histidine, and lysine), to afford a viable and storable drug product.

Liquid pharmaceutical composition of etanercept with lysine and proline

Growing community of inventors

Munich, Germany

Andrea Hawe